3 years ago

The influence of histology on the response of brain metastases to gamma knife radiosurgery: a propensity score-matched study

Kyung Hwan Kim, Min Ho Lee, Kyung-Rae Cho, Jung-Won Choi, Doo-Sik Kong, Ho Jun Seol, Do-Hyun Nam, Jung-Il Lee

Abstract

Background

In terms of response to fractionated radiotherapy, metastatic brain tumors of certain origins are considered radioresistant.

Objective

To determine the influence of “radioresistant” histology on outcomes of brain metastases treated with radiosurgery.

Methods

Between 2001 and 2017, 121 patients with brain metastases from renal cell carcinoma (RCC) and 2151 from non-small cell lung cancer (NSCLC) were reviewed. Eighty-seven pairs were derived using propensity score matching. Local progression-free survival (PFS), progression patterns, distant PFS, and overall survival were investigated.

Results

The median follow-up period was 13.7 months (range, 1.6–78.4 months). A total of 536 lesions were treated using gamma knife radiosurgery (GKS), with a median dose of 20 Gy (range, 12–28 Gy). The actuarial local PFS rates in the RCC group were 91% and 89% at 6 and 12 months, respectively, and did not differ from the NSCLC group (97% and 83% at 6 and 12 months, respectively). Continuous progression, without response to GKS, was noted in seven of the eight progressed RCCs. However, six of the seven progressed NSCLCs showed transient shrinkage before progression. The median distant PFS was 9.3 months (95% CI, 6.3–12.2) in the RCC group and 8.0 months (95% CI, 5.5–10.4) in the NSCLC group. The median overall survival was 16.1 months (95% CI, 11.3–20.8) and 14.9 months (95% CI, 11.9–17.8) in RCC and NSCLC groups, respectively.

Conclusion

Histological differences had no effect on local control in the single high-dose range used for radiosurgery. However, changes in tumor volume during progression varied across tumor histology.

Publisher URL: https://link.springer.com/article/10.1007/s00701-018-3726-2

DOI: 10.1007/s00701-018-3726-2

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.